Mast cell-derived exosomes activate endothelial cells to secrete plasminogen activator inhibitor type 1

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 8, 2005, Pages 1744-1749

  Al Nedawi, Khalid ^a   Szemraj, Janusz ^a   Cierniewski, Czeslaw S ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Exosomes; Mast cells; Plasminogen activator inhibitor type 1; Prothrombinase complex

Indexed keywords

2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; ANGIOTENSINOGEN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A INHIBITOR; CHROMOGENIC SUBSTRATE; HIRUDIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN;

ARTICLE; CELL COMMUNICATION; CELL TRANSFER; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; MAST CELL; NONHUMAN; PLASMINOGEN ACTIVATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SYNDROME DELINEATION;

CELL COMMUNICATION; ENDOTHELIUM, VASCULAR; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION; HUMANS; MAST CELLS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOMICS; RNA, MESSENGER; THROMBIN; U937 CELLS; UMBILICAL VEINS; UP-REGULATION;

EID: 23244456496     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000172007.86541.76     Document Type: Article

References (30)

1. Black PH. Shedding from the cell surface of normal and cancer cells. Adv Cancer Rex. 1980;32:75-199.
2. George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients with adult respiratory distress syndrome and cardiac surgery. J Clin Invest. 1986;78:340-348.
3. Armstrong M, Storch J, Dainiak N. Stimulating distinct plasma membrane regions gives rise to extracellular membrane vesicles in normal and transformed lymphocytes. Biochem Biophys Acta. 1988;946:106-111.
4. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PGM, ten Have K, Eijsman L, Hack CE, Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation. 1997;96:3534-3541.
5. Singh N, Gcmmell CH, Daly PA, Yeo EL. Elevated platelet-derived microparticle levels during unstable angina. Can J Cardiol. 1995;11:1015-1021.
6. Lee YJ, Jy W, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts and multiinfarct dementia. Thromb Res. 1996;72:295-304.
7. Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T, Kido H, Kagawa H, Fukuhara S. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 1995;116:235-240.
8. Metcalfe DD, Baram D, Mekori YA. Mast cells) Physiol. Rev. 1997;77:1033-1079.
9. Ramos BF, Zhang Y, Jakschik BA. Mast cells contribute to fibrin deposition in reverse passive Arthus reaction in mouse skin. Eur J Immunol. 1992;22:2381-2385.
10. Zhang Y, Ramos BF, Jakschik BA. The tole of mast cells and their mediators in IgG-antigen complex-mediated inflammation. Am J Ther. 1995;10:761-767.
11. Burgoyne, R. D., and Morgan, A. Secretory granule exocytosis (2003) Physiol Rev. 2003;83:581-632.
12. Jaffe EA, Minick R, Adelman B, Becker CG, Nachman RL. Synthesis of basement membrane collagen by cultured human endothelial cells. J Exp Med. 1976;144:209-221.
13. Cieslak M, Niewiarowska J, Nawrot M, Koziolkiewicz M, Stec WJ, Ciernicwski CS. DNAzymes to beta 1 and beta 3 mRNA down-regulate expression of the targeted integrins and inhibit endothelial cell capillary tube formation in fibrin and matrigel. J Biol Chem. 2002;277:6779-6678.
14. Emeis JJ, Edgell CJ. Fibrinolytic properties of a human endothelial hybrid cell line (Ea. hy 926). Blood. 1988;71:1669-1675.
15. Bouis D, Hospers GA, Meijer C, Molema G, Mulder NH. Endothelium in vitro: a review of human vascular endothelia cell lines for blood vessel-related research. Angiogenesis. 2001;4:91-12.
16. Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, David B, Namane A, Mecheri S. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol. 2001;166:868-876.
17. Sundstrom M, Vliagoftis H, Karlberg P, Butterfield JH, Nilsson K, Metcalfe DD, Nilsson G. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene. Immunology. 2003;108:89-97.
18. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest. 1993;92:1736-1744.
19. Yamatodani A. H. Fukuda, H. Wada, T. Iwaeda, T. Watanabe. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. J Chromatogr. 1985;344:115-123.
20. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999;270:41-49.
21. Shevehenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1966;68:850-858.
22. Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation. 2002;106:2372-2378.
23. Boncela J, Papiewska I, Fijalkowska I, Walkowiak B, Cierniewski CS. Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type I and stabilizes its inhibitory activity. J Biol Chem. 2001;276:35305-35311.
24. Skokos D, Botros HG, Demeure C, Morin J, Peronet R, Birkenmeier G, Boudaly S, Mecheri S. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol. 2003;170:3037-3045.
25. Kaartinen M, Penttila A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 1994;90:1669-1678.
26. Padro T, Steins M, Li CX, Mesters RM, Hammel D, Scheld HH, Kienast J. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants. Cardiovasc Res. 1997;36:28-36.
27. Fearns C, Loskutoff DJ. Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-alfa. Am J Pathol. 1997;150:579-590.
28. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest. 1995;95:1353-1362.
29. Dichek D, Quertermous T. Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. Blood. 1989;74:222-228.
30. Shen GX, Ren S. Fenton JW 2nd. Transcellular signaling and pharmacological modulation of thrombin-induced production of plasminogen activator inhibitor-1 in vascular smooth muscle cells. Semin Thromb Hemost. 1998;24:151-156.